Novo Nordisk to Invest €430 Million in Irish Plant for Weight Loss Drug Production

Pharmaceutical company Novo Nordisk announced a €430 million expansion of its manufacturing operation in Athlone, Ireland, to produce the tablet form of its weight loss drug Wegovy.

2 Mar, 09:31 — 2 Mar, 09:31

Post Share

ℹOnly 1 source covers this story

Read at source (1 outlet)

rte-news3d ago

Novo Nordisk to invest €430m in Athlone plant

Pharmaceutical company Novo Nordisk has announced a €430m expansion of its manufacturing operation in Athlone which will see it produce the tablet form of its weight loss drug Wegovy.

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk to Invest €430 Million in Irish Plant for Weight Loss Drug Production

Read at source (1 outlet)

Novo Nordisk to invest €430m in Athlone plant

Related Stories

NBI raids in Binondo yield over P237-M fake goods

Fry scarcity hits ‘bangus’ growers in Pangasinan

Philippine DA orders nationwide survey over seed and machinery issues

Commentary: How the war in Iran could impact global economy, including Singapore

PERSPECTA